Submission Details
| 510(k) Number | K063090 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 10, 2006 |
| Decision Date | March 27, 2007 |
| Days to Decision | 168 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K063090 is an FDA 510(k) clearance for the MEDRAD STELLANT CT INJECTOR SYSTEM WITH XDS ACCESSORY, a Injector, Contrast Medium, Automatic (Class II — Special Controls, product code IZQ), submitted by Medrad, Inc. (Indianola, US). The FDA issued a Cleared decision on March 27, 2007, 168 days after receiving the submission on October 10, 2006. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1650.
| 510(k) Number | K063090 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 10, 2006 |
| Decision Date | March 27, 2007 |
| Days to Decision | 168 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | IZQ — Injector, Contrast Medium, Automatic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1650 |